Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GERN
GYRE
Add up to 3 more stocks
GERN
Geron Corporation
+1.24%
$1.23+0.02Delayed quote: Oct 6, 2026, 11:20 AM EDT
Market Cap
$785.86M
52W Range
$1.04 - $2.01
GYRE
Gyre Therapeutics, Inc.
-2.86%
$7.14-0.21Delayed quote: Oct 6, 2026, 11:19 AM EDT
Market Cap
$796.03M
52W Range
$5.44 - $9.42
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.59 | 7.38 |
| P/S Ratio | 3.84 | 6.67 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 97.4% | 94.3% |
| Operating Margin | -29.3% | 9.9% |
| Net Margin | -34.2% | -14.5% |
| ROE | -32.0% | -13.3% |
| ROA | -13.5% | -8.7% |
| ROIC | -8.3% | -9.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 6.92 | 4.26 |
| Quick Ratio | 5.16 | 3.86 |
| Debt/Equity | 0.56 | 0.03 |
| Interest Coverage | -1.65 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.